Clinical Trials Browser

Phase EARLY_PHASE1 × lenvatinib × 1 year × Clear all

NCT05733715 2026-03-24

Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma

Phase EARLY_PHASE1 Recruiting

Carcinoma, Renal Cell

NCT07356466 2026-01-21

FUGES032

Phase EARLY_PHASE1 Enrolling by invitation

Gastrointestinal

Stomach Neoplasms

NCT05041153 2026-01-12

Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Advanced Gastric Adenocarcinoma